Hepatitis Monthly

Published by: Kowsar

Potential Mutations Associated With Occult Hepatitis B Virus Status

Sima Besharat 1 , 2 , Aezam Katoonizadeh 1 and Abdolvahab Moradi 2 , *
Authors Information
1 Liver and Pancreatobiliary Diseases Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, IR Iran
2 Golestan Research Center of Gastroentrology and Hepatology, Golestan University of Medical Sciences, Gorgan, IR Iran
Article information
  • Hepatitis Monthly: May 2014, 14 (5); e15275
  • Published Online: May 3, 2014
  • Article Type: Review Article
  • Received: October 6, 2013
  • Revised: January 14, 2014
  • Accepted: February 20, 2014
  • DOI: 10.5812/hepatmon.15275

To Cite: Besharat S, Katoonizadeh A, Moradi A. Potential Mutations Associated With Occult Hepatitis B Virus Status, Hepat Mon. 2014 ;14(5):e15275. doi: 10.5812/hepatmon.15275.

Abstract
Copyright: Copyright © 2014, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
Acknowledgements
Footnotes
References
  • 1. Ocana S, Casas ML, Buhigas I, Lledo JL. Diagnostic strategy for occult hepatitis B virus infection. World J Gastroenterol. 2011; 17(12): 1553-7[DOI][PubMed]
  • 2. de la Fuente RA, Gutierrez ML, Garcia-Samaniego J, Fernandez-Rodriguez C, Lledo JL, Castellano G. Pathogenesis of occult chronic hepatitis B virus infection. World J Gastroenterol. 2011; 17(12): 1543-8[DOI][PubMed]
  • 3. Han YF, Zhao J, Ma LY, Yin JH, Chang WJ, Zhang HW, et al. Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma. World J Gastroenterol. 2011; 17(38): 4258-70[DOI][PubMed]
  • 4. Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol. 2008; 49(4): 652-7[DOI][PubMed]
  • 5. Dandri M, Locarnini S. New insight in the pathobiology of hepatitis B virus infection. Gut. 2012; 61 Suppl 1-17[DOI][PubMed]
  • 6. Said ZN. An overview of occult hepatitis B virus infection. World J Gastroenterol. 2011; 17(15): 1927-38[DOI][PubMed]
  • 7. Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B virus infection. J Hepatol. 2007; 46(1): 160-70[DOI][PubMed]
  • 8. Dienstag JL. Hepatitis B virus infection. N Engl J Med. 2008; 359(14): 1486-500[DOI][PubMed]
  • 9. Nguyen DH, Ludgate L, Hu J. Hepatitis B virus-cell interactions and pathogenesis. J Cell Physiol. 2008; 216(2): 289-94[DOI][PubMed]
  • 10. Chang JJ, Lewin SR. Immunopathogenesis of hepatitis B virus infection. Immunol Cell Biol. 2007; 85(1): 16-23[DOI][PubMed]
  • 11. Martin CM, Welge JA, Shire NJ, Rouster SD, Shata MT, Sherman KE, et al. Genomic variability associated with the presence of occult hepatitis B virus in HIV co-infected individuals. J Viral Hepat. 2010; 17(8): 588-97[DOI][PubMed]
  • 12. Bruni R, Prosperi M, Marcantonio C, Amadori A, Villano U, Tritarelli E, et al. A computational approach to identify point mutations associated with occult hepatitis B: significant mutations affect coding regions but not regulative elements of HBV. Virol J. 2011; 8: 394[DOI][PubMed]
  • 13. Mohammadkhani A, Montazeri G, Poustchi H. The Importance of Hepatitis B Virus Genome Diversity in Basal Core Promoter Region. Middle East J Dig Dis. 2011; 3(1): 13-9
  • 14. Kramvis A, Kew M, Francois G. Hepatitis B virus genotypes. Vaccine. 2005; 23(19): 2409-23[DOI][PubMed]
  • 15. Raimondo G, Caccamo G, Filomia R, Pollicino T. Occult HBV infection. Semin Immunopathol. 2013; 35(1): 39-52[DOI][PubMed]
  • 16. Hou J, Wang Z, Cheng J, Lin Y, Lau GK, Sun J, et al. Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology. 2001; 34(5): 1027-34[DOI][PubMed]
  • 17. Ma Q, Wang Y. Comprehensive analysis of the prevalence of hepatitis B virus escape mutations in the major hydrophilic region of surface antigen. J Med Virol. 2012; 84(2): 198-206[DOI][PubMed]
  • 18. Liu Y, Li P, Li C, Zhou J, Wu C, Zhou YH. Detection of hepatitis B virus DNA among accepted blood donors in Nanjing, China. Virol J. 2010; 7: 193[DOI][PubMed]
  • 19. Yuan Q, Ou SH, Chen CR, Ge SX, Pei B, Chen QR, et al. Molecular characteristics of occult hepatitis B virus from blood donors in southeast China. J Clin Microbiol. 2010; 48(2): 357-62[DOI][PubMed]
  • 20. Panigrahi R, Biswas A, Datta S, Banerjee A, Chandra PK, Mahapatra PK, et al. Anti-hepatitis B core antigen testing with detection and characterization of occult hepatitis B virus by an in-house nucleic acid testing among blood donors in Behrampur, Ganjam, Orissa in southeastern India: implications for transfusion. Virol J. 2010; 7: 204[DOI][PubMed]
  • 21. Huang C-H, Yuan Q, Chen P-J, Zhang Y-L, Chen C-R, Zheng Q-B, et al. Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors. J Hepatol. 2012; 57(4): 720-9
  • 22. Sengupta S, Rehman S, Durgapal H, Acharya SK, Panda SK. Role of surface promoter mutations in hepatitis B surface antigen production and secretion in occult hepatitis B virus infection. J Med Virol. 2007; 79(3): 220-8[DOI][PubMed]
  • 23. Chen CJ, Yang HI. Natural history of chronic hepatitis B REVEALed. J Gastroenterol Hepatol. 2011; 26(4): 628-38[DOI][PubMed]
  • 24. Pollicino T, Raffa G, Costantino L, Lisa A, Campello C, Squadrito G, et al. Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. Hepatology. 2007; 45(2): 277-85[DOI][PubMed]
  • 25. Chaudhuri V, Tayal R, Nayak B, Acharya SK, Panda SK. Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter. Gastroenterology. 2004; 127(5): 1356-71[PubMed]
  • 26. Ito K, Qin Y, Guarnieri M, Garcia T, Kwei K, Mizokami M, et al. Impairment of hepatitis B virus virion secretion by single-amino-acid substitutions in the small envelope protein and rescue by a novel glycosylation site. J Virol. 2010; 84(24): 12850-61[DOI][PubMed]
  • 27. Sheldon J, Soriano V. Hepatitis B virus escape mutants induced by antiviral therapy. J Antimicrob Chemother. 2008; 61(4): 766-8[DOI][PubMed]
  • 28. Hass M, Hannoun C, Kalinina T, Sommer G, Manegold C, Gunther S. Functional analysis of hepatitis B virus reactivating in hepatitis B surface antigen-negative individuals. Hepatology. 2005; 42(1): 93-103[DOI][PubMed]
  • 29. Fukuda R, Ishimura N, Kushiyama Y, Moriyama N, Ishihara S, Chowdhury A, et al. Hepatitis B virus with X gene mutation is associated with the majority of serologically "silent" non-b, non-c chronic hepatitis. Microbiol Immunol. 1996; 40(7): 481-8[PubMed]
  • 30. Fujise K, Tatsuzawa K, Kono M, Hoshina S, Tsubota A, Niiya M, et al. A mutation of the start codon in the X region of hepatitis B virus DNA in a patient with non-B, non-C chronic hepatitis. World J Hepatol. 2011; 3(2): 56-60[DOI][PubMed]
  • 31. Chen SJ, Zhao YX, Fang Y, Xu WZ, Ma YX, Song ZW, et al. Viral deletions among healthy young Chinese adults with occult hepatitis B virus infection. Virus Res. 2012; 163(1): 197-201[DOI][PubMed]
  • 32. Fang ZL, Zhuang H, Wang XY, Ge XM, Harrison TJ. Hepatitis B virus genotypes, phylogeny and occult infection in a region with a high incidence of hepatocellular carcinoma in China. World J Gastroenterol. 2004; 10(22): 3264-8[PubMed]
  • 33. Garcia-Montalvo BM, Ventura-Zapata LP. Molecular and serological characterization of occult hepatitis B infection in blood donors from Mexico. Ann Hepatol. 2011; 10(2): 133-41[PubMed]
  • 34. Chotiyaputta W, Lok AS. Hepatitis B virus variants. Nat Rev Gastroenterol Hepatol. 2009; 6(8): 453-62[DOI][PubMed]
  • 35. Hsu CW, Yeh CT. Emergence of hepatitis B virus S gene mutants in patients experiencing hepatitis B surface antigen seroconversion after peginterferon therapy. Hepatology. 2011; 54(1): 101-8[DOI][PubMed]
  • 36. Tang H, Oishi N, Kaneko S, Murakami S. Molecular functions and biological roles of hepatitis B virus x protein. Cancer Sci. 2006; 97(10): 977-83
  • 37. Wei Y, Neuveut C, Tiollais P, Buendia MA. Molecular biology of the hepatitis B virus and role of the X gene. Pathol Biol (Paris). 2010; 58(4): 267-72[PubMed]
  • 38. Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev. 2000; 64(1): 51-68[PubMed]
  • 39. Murakami S. Hepatitis B virus X protein: a multifunctional viral regulator. J Gastroenterol. 2001; 36(10): 651-60[PubMed]
  • 40. Roseman AM, Borschukova O, Berriman JA, Wynne SA, Pumpens P, Crowther RA. Structures of hepatitis B virus cores presenting a model epitope and their complexes with antibodies. J Mol Biol. 2012; 423(1): 63-78
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader